New weight-loss pill ‘better than jabs’

Those taking amycretin lost almost a quarter of their body weight in 36 weeks, the best result yet for a GLP drug

venerdì 20 giugno 2025 New tab

569 words~3 min read

Those taking amycretin lost almost a quarter of their body weight in 36 weeks, the best result yet for a GLP drug

Copy link

twitter

facebook

Other newsrooms on this story

· 4 sources

· 4 sources

Eli Lilly’s orforglipron could offer needle-free alternative to weight-loss jabs at lower cost

telegraph.co.uk9 mesi fa

Participants in trial of amycretin injectable obesity drug lost an average of 24% of their body weight on highest dose

ft.com10 mesi fa

The tablet - orforglipron - is available in the US and could soon launch in the UK.

bbc.com2 g fa

GLP-1 users likely to regain two-thirds of the weight they lost within a year, study shows

independent.co.uk2 mesi fa

Orforglipron works by lowering blood sugar levels, slowing food digestion and reducing appetite

independent.co.uk2 g fa

Novo Nordisk said its experimental drug, amycretin, showed statistically significant weight loss of up to 14.5% at 36 weeks in…

cnbc.com5 mesi fa